ARCHIVES

SWOG Phase III Trial To Test Treatment For Inoperable, Locally Advanced NSCLC

This article is from The Cancer Letter archive.

Vol. 24 No. 9 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

Senate “Pleased” About Reductions In Incidence And Mortality

October 8, 1999

Litton’s New Fredrick Award Could Total Around $30 Million

July 30, 1976

In Brief: Upton Still Pondering Location Of Centers, Other Program; Moves Could Involve DCCR

April 27, 1979

Bepler To Lead Karmanos Cancer Institute

January 29, 2010

In Brief: Schweitzer ACS President, Dodd President Elect, FDA Commissioner Resigns Abruptly

November 17, 1989

Breast Cancer Incidence Reduced 45% In Tamoxifen Arm Of BCPT; Trial Unblinded

April 10, 1998